These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15908183)

  • 21. Direct transition to long-acting risperidone--analysis of long-term efficacy.
    Kissling W; Heres S; Lloyd K; Sacchetti E; Bouhours P; Medori R; Llorca PM
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):15-21. PubMed ID: 16144782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.
    Kane JM; Eerdekens M; Lindenmayer JP; Keith SJ; Lesem M; Karcher K
    Am J Psychiatry; 2003 Jun; 160(6):1125-32. PubMed ID: 12777271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.
    Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G
    J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.
    Simpson GM; Mahmoud RA; Lasser RA; Kujawa M; Bossie CA; Turkoz I; Rodriguez S; Gharabawi GM
    J Clin Psychiatry; 2006 Aug; 67(8):1194-203. PubMed ID: 16965196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia.
    Lenert LA; Rupnow MF; Elnitsky C
    Health Qual Life Outcomes; 2005 Sep; 3():57. PubMed ID: 16153308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia.
    Macfadden W; Bossie CA; Turkoz I; Haskins JT
    Int Clin Psychopharmacol; 2010 Mar; 25(2):75-82. PubMed ID: 20101185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
    Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone.
    Schmauss M; Sacchetti E; Kahn JP; Medori R
    Int Clin Psychopharmacol; 2007 Mar; 22(2):85-92. PubMed ID: 17293708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.
    Leatherman SM; Liang MH; Krystal JH; Lew RA; Valley D; Thwin SS; Rosenheck RA;
    J Nerv Ment Dis; 2014 Jan; 202(1):13-7. PubMed ID: 24375206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting risperidone improves negative symptoms in stable psychotic patients.
    Curtis VA; Katsafouros K; Möller HJ; Medori R; Sacchetti E
    J Psychopharmacol; 2008 May; 22(3):254-61. PubMed ID: 18308804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety.
    Hawley C; Turner M; Latif MA; Curtis V; Saleem PT; Wilton K
    Hum Psychopharmacol; 2010 Jan; 25(1):37-46. PubMed ID: 20041474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia.
    Arunpongpaisal S; Srisurapanont M; Kongsakon R; Kitiwattanagul K; Samanwongthai U
    J Med Assoc Thai; 2010 Mar; 93(3):343-50. PubMed ID: 20420110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome.
    Lloyd K; Latif MA; Simpson S; Shrestha KL
    Hum Psychopharmacol; 2010 Apr; 25(3):243-52. PubMed ID: 20373476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].
    Sárosi A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):179-87. PubMed ID: 17211053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to long-acting risperidone.
    van Os J; Bossie CA; Lasser RA
    Int Clin Psychopharmacol; 2004 Jul; 19(4):229-32. PubMed ID: 15201570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
    Turner M; Eerdekens E; Jacko M; Eerdekens M
    Int Clin Psychopharmacol; 2004 Jul; 19(4):241-9. PubMed ID: 15201572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone.
    Tadger S; Baruch Y; Barak Y
    Int Psychogeriatr; 2008 Dec; 20(6):1245-50. PubMed ID: 18620626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study.
    Procyshyn RM; Barr AM; Flynn S; Schenk C; Ganesan S; Honer WG
    Schizophr Res; 2010 Nov; 123(2-3):273-5. PubMed ID: 20688481
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term treatment with long-acting risperidone in Korean patients with schizophrenia.
    Lee MS; Ko YH; Lee SH; Seo YJ; Kim SH; Joe SH; Han CS; Lee JH; Jung IK
    Hum Psychopharmacol; 2006 Aug; 21(6):399-407. PubMed ID: 16915580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.